Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Ophthalmology

  Free Subscription


Articles published in J Ocul Pharmacol Ther

Retrieve available abstracts of 166 articles:
HTML format
Text format



Single Articles


    June 2018
  1. NOVACK GD
    Pharmacokinetic Analysis of Intraocular Penetration of Latanoprost Solutions with Different Preservatives in Human Eyes.
    J Ocul Pharmacol Ther. 2018 Jun 20. doi: 10.1089/jop.2018.0048.
    PubMed     Text format    


    May 2018
  2. KAKIMOTO H, Takamura Y, Arimura S, Miyake S, et al
    Effect of 0.05% Difluprednate Ophthalmic Emulsion on Proinflammatory Cytokine Levels After Retinal Laser Photocoagulation in Rabbits.
    J Ocul Pharmacol Ther. 2018 May 29. doi: 10.1089/jop.2017.0109.
    PubMed     Text format     Abstract available


  3. ZHAO X, Tong Y, Wang X, Zhang X, et al
    Comparison of the Ocular Penetration and Pharmacokinetics Between Natamycin and Voriconazole After Topical Instillation in Rabbits.
    J Ocul Pharmacol Ther. 2018 May 24. doi: 10.1089/jop.2017.0139.
    PubMed     Text format     Abstract available


  4. CHAKRAVARTI T
    The Association of Socioeconomic Status with Severity of Glaucoma and the Impacts of Both Factors on the Costs of Glaucoma Medications: A Cross-Sectional Study in West Bengal, India.
    J Ocul Pharmacol Ther. 2018 May 15. doi: 10.1089/jop.2017.0135.
    PubMed     Text format     Abstract available


  5. CHO YK, Shin EY, Uehara H, Ambati B, et al
    The Effect of 0.5% Timolol Maleate on Corneal(Lymph)Angiogenesis in a Murine Suture Model.
    J Ocul Pharmacol Ther. 2018 May 14. doi: 10.1089/jop.2017.0119.
    PubMed     Text format     Abstract available


  6. TRAN HDM, Tran YH, Tran TD, Jong M, et al
    A Review of Myopia Control with Atropine.
    J Ocul Pharmacol Ther. 2018 May 1. doi: 10.1089/jop.2017.0144.
    PubMed     Text format     Abstract available


    April 2018
  7. SMITH A, Pawar M, Van Dort ME, Galban S, et al
    Ocular Toxicity Profile of ST-162 and ST-168 as Novel Bifunctional MEK/PI3K Inhibitors.
    J Ocul Pharmacol Ther. 2018 Apr 30. doi: 10.1089/jop.2017.0126.
    PubMed     Text format     Abstract available


  8. GARAY-ARAMBURU G, Gomez-Moreno A
    A 5-Year Follow-Up Study of the Treatment of Macular Edema Due to Retinal Vein Occlusion Using Dexamethasone Intravitreal Implants.
    J Ocul Pharmacol Ther. 2018 Apr 30. doi: 10.1089/jop.2017.0148.
    PubMed     Text format     Abstract available


  9. BAIZA-DURAN L, Olvera-Montano O, Mercado-Sesma AR, Oregon-Miranda AA, et al
    Efficacy and Safety of 0.6% Pazufloxacin Ophthalmic Solution Versus Moxifloxacin 0.5% and Gatifloxacin 0.5% in Subjects with Bacterial Conjunctivitis: A Randomized Clinical Trial.
    J Ocul Pharmacol Ther. 2018;34:250-255.
    PubMed     Text format     Abstract available


    March 2018
  10. RUANGVARAVATE N, Prabhasawat P, Vachirasakchai V, Tantimala R, et al
    High Prevalence of Ocular Surface Disease Among Glaucoma Patients in Thailand.
    J Ocul Pharmacol Ther. 2018 Mar 29. doi: 10.1089/jop.2017.0104.
    PubMed     Text format     Abstract available


  11. ZHU S, Xu X, Liu K, Gu Q, et al
    PAPep Inhibits Secretion of Poly(I:C)-Induced Inflammatory Cytokines and ICAM-1 Expression in Corneal Fibroblasts by Suppressing the NF-kappaB/p38 Pathway.
    J Ocul Pharmacol Ther. 2018 Mar 27. doi: 10.1089/jop.2017.0068.
    PubMed     Text format     Abstract available


    February 2018
  12. NOVACK GD, Moyer ED
    Slit Lamp-Based Ocular Scoring Systems: Commentary.
    J Ocul Pharmacol Ther. 2018 Feb 26. doi: 10.1089/jop.2018.29039.
    PubMed     Text format    


  13. KAZEMI A, McLaren JW, Kopczynski CC, Heah TG, et al
    The Effects of Netarsudil Ophthalmic Solution on Aqueous Humor Dynamics in a Randomized Study in Humans.
    J Ocul Pharmacol Ther. 2018 Feb 22. doi: 10.1089/jop.2017.0138.
    PubMed     Text format     Abstract available


  14. OZGONUL C, Dedania VS, Besirli CG
    Aflibercept Versus Bevacizumab and/or Ranibizumab for Recurrent Macular Edema Secondary to Central Retinal Vein Occlusion.
    J Ocul Pharmacol Ther. 2018 Feb 15. doi: 10.1089/jop.2017.0074.
    PubMed     Text format     Abstract available


  15. UCAN GUNDUZ G, Parmak Yener N, Kilincel O, Gunduz C, et al
    How Does Usage of Serotonin Noradrenaline Reuptake Inhibitors Affect Intraocular Pressure in Depression Patients?
    J Ocul Pharmacol Ther. 2018 Feb 15. doi: 10.1089/jop.2017.0133.
    PubMed     Text format     Abstract available


  16. PAPANGKORN K, Higuchi JW, Brar B, Higuchi WI, et al
    Ocular Drug Distribution and Safety of a Noninvasive Ocular Drug Delivery System of Dexamethasone Sodium Phosphate in Rabbit.
    J Ocul Pharmacol Ther. 2018 Feb 12. doi: 10.1089/jop.2017.0093.
    PubMed     Text format     Abstract available


  17. BACHU RD, Stepanski M, Alzhrani RM, Jung R, et al
    Development and Evaluation of a Novel Microemulsion of Dexamethasone and Tobramycin for Topical Ocular Administration.
    J Ocul Pharmacol Ther. 2018 Feb 6. doi: 10.1089/jop.2017.0082.
    PubMed     Text format     Abstract available


  18. CARLSON E, Kao WWY, Ogundele A
    Impact of Hyaluronic Acid-Containing Artificial Tear Products on Reepithelialization in an In Vivo Corneal Wound Model.
    J Ocul Pharmacol Ther. 2018 Feb 2. doi: 10.1089/jop.2017.0080.
    PubMed     Text format     Abstract available



  19. Correction to: The Effect of Posture on Intraocular Pressure and Systemic Hemodynamic Parameters in Treated and Untreated Patients with Primary Open-Angle Glaucoma, by Katsanos, A., Dastiridou, A.I., Quaranta, L., Rulli, E., Riva, I., Dimasi, V., Tsir
    J Ocul Pharmacol Ther. 2018 Feb 2. doi: 10.1089/jop.2017.0030.
    PubMed     Text format    


  20. DINC E, Ayaz L, Kurt AH
    Effects of Bevacizumab, Ranibizumab, and Aflibercept on MicroRNA Expression in a Retinal Pigment Epithelium Cell Culture Model of Oxidative Stress.
    J Ocul Pharmacol Ther. 2018 Feb 1. doi: 10.1089/jop.2017.0128.
    PubMed     Text format     Abstract available


  21. YAZICI A, Sari E, Ayhan E, Sahin G, et al
    The Effect of Low-Dose Aspirin on Dry Eye Parameters and Ocular Surface Disease Index Questionnaire.
    J Ocul Pharmacol Ther. 2018 Feb 1. doi: 10.1089/jop.2017.0064.
    PubMed     Text format     Abstract available


    January 2018
  22. KARACA ADIYEKE S, Ture G, Talay E
    Intravitreal Dexamethasone Implant for Postvitrectomy Macular Edema: A Retrospective Cohort of 14 Patients (Postvitrectomy Macular Edema Treatment).
    J Ocul Pharmacol Ther. 2018 Jan 29. doi: 10.1089/jop.2017.0107.
    PubMed     Text format     Abstract available


  23. NJIE-MBYE YF, Robinson J, Mitchell-Bush L, Mckoy M, et al
    Pharmacology of Serotonin Receptors Causing Contraction of Isolated Bovine Posterior Ciliary Arteries: Role in Ocular Blood Flow.
    J Ocul Pharmacol Ther. 2018 Jan 25. doi: 10.1089/jop.2017.0124.
    PubMed     Text format     Abstract available


  24. OHIA SE, Njie-Mbye YF, Robinson J, Mitchell L, et al
    Serotonin-2B/2C Receptors Mediate Bovine Ciliary Muscle Contraction: Role in Intraocular Pressure Regulation.
    J Ocul Pharmacol Ther. 2018 Jan 24. doi: 10.1089/jop.2017.0123.
    PubMed     Text format     Abstract available


  25. SINGH S, Agarwal R, Abdul Razak Z, Ngu R, et al
    Ocular Permeation of Topical Tazocin and Its Effectiveness in the Treatment of Pseudomonas aeruginosa Induced Keratitis in Rabbits.
    J Ocul Pharmacol Ther. 2018 Jan 17. doi: 10.1089/jop.2017.0098.
    PubMed     Text format     Abstract available


  26. SHARIF NA
    iDrugs and iDevices Discovery Research: Preclinical Assays, Techniques, and Animal Model Studies for Ocular Hypotensives and Neuroprotectants.
    J Ocul Pharmacol Ther. 2018 Jan 11. doi: 10.1089/jop.2017.0125.
    PubMed     Text format     Abstract available


  27. SEKINE Y, Shimada M, Satake S, Okubo M, et al
    Pharmacokinetic Analysis of Intraocular Penetration of Latanoprost Solutions with Different Preservatives in Human Eyes.
    J Ocul Pharmacol Ther. 2018 Jan 11. doi: 10.1089/jop.2017.0091.
    PubMed     Text format     Abstract available


  28. JIN SW, Lee SM
    The Efficacy and Safety of the Fixed Combination of Brinzolamide 1% and Brimonidine 0.2% in Normal Tension Glaucoma: An 18-Month Retrospective Study.
    J Ocul Pharmacol Ther. 2018 Jan 3. doi: 10.1089/jop.2017.0075.
    PubMed     Text format     Abstract available


    December 2017
  29. CHUNG JK, Spencer E, Hunt M, McCauley T, et al
    Ocular Distribution and Pharmacokinetics of Lifitegrast in Pigmented Rabbits and Mass Balance in Beagle Dogs.
    J Ocul Pharmacol Ther. 2017 Dec 21. doi: 10.1089/jop.2017.0106.
    PubMed     Text format     Abstract available


  30. EKANAYAKA SA, McClellan SA, Barrett RP, Hazlett LD, et al
    Topical Glycyrrhizin Is Therapeutic for Pseudomonas aeruginosa Keratitis.
    J Ocul Pharmacol Ther. 2017 Dec 13. doi: 10.1089/jop.2017.0094.
    PubMed     Text format     Abstract available


  31. WATERBURY LD
    Alternative Drug Delivery for Patients Undergoing Cataract Surgery as Demonstrated in a Canine Model.
    J Ocul Pharmacol Ther. 2017 Dec 11. doi: 10.1089/jop.2017.0048.
    PubMed     Text format     Abstract available


  32. OHIA SE, Robinson J, Mitchell L, Ngele KK, et al
    Regulation of Aqueous Humor Dynamics by Hydrogen Sulfide: Potential Role in Glaucoma Pharmacotherapy.
    J Ocul Pharmacol Ther. 2017 Dec 7. doi: 10.1089/jop.2017.0077.
    PubMed     Text format     Abstract available


  33. SCHMITT HM, Schlamp CL, Nickells RW
    Targeting HDAC3 Activity with RGFP966 Protects Against Retinal Ganglion Cell Nuclear Atrophy and Apoptosis After Optic Nerve Injury.
    J Ocul Pharmacol Ther. 2017 Dec 6. doi: 10.1089/jop.2017.0059.
    PubMed     Text format     Abstract available


  34. KHAN S, Warade S, Singhavi DJ
    Improvement in Ocular Bioavailability and Prolonged Delivery of Tobramycin Sulfate Following Topical Ophthalmic Administration of Drug-Loaded Mucoadhesive Microparticles Incorporated in Thermosensitive In Situ Gel.
    J Ocul Pharmacol Ther. 2017 Dec 6. doi: 10.1089/jop.2017.0079.
    PubMed     Text format     Abstract available


  35. HARTMAN RR, Kompella UB
    Intravitreal, Subretinal, and Suprachoroidal Injections: Evolution of Microneedles for Drug Delivery.
    J Ocul Pharmacol Ther. 2017 Dec 5. doi: 10.1089/jop.2017.0121.
    PubMed     Text format     Abstract available


  36. EATON JS, Miller PE, Bentley E, Thomasy SM, et al
    The SPOTS System: An Ocular Scoring System Optimized for Use in Modern Preclinical Drug Development and Toxicology.
    J Ocul Pharmacol Ther. 2017;33:718-734.
    PubMed     Text format     Abstract available


    November 2017
  37. MASUOKA T, Gallar J, Belmonte C
    Inhibitory Effect of Amitriptyline on the Impulse Activity of Cold Thermoreceptor Terminals of Intact and Tear-Deficient Guinea Pig Corneas.
    J Ocul Pharmacol Ther. 2017 Nov 29. doi: 10.1089/jop.2017.0066.
    PubMed     Text format     Abstract available


  38. CHEN Y, Hua R
    Therapeutic Efficacy of Conbercept for Inflammatory Choroidal Neovascularization.
    J Ocul Pharmacol Ther. 2017 Nov 29. doi: 10.1089/jop.2017.0097.
    PubMed     Text format    


  39. BANTSEEV V, Erickson R, Leipold D, Amaya C, et al
    Nonclinical Safety Assessment of Anti-Factor D: Key Strategies and Challenges for the Nonclinical Development of Intravitreal Biologics.
    J Ocul Pharmacol Ther. 2017 Nov 17. doi: 10.1089/jop.2017.0063.
    PubMed     Text format     Abstract available


  40. MIOTTO S, Zemella N, Gusson E, Panozzo G, et al
    Morphologic Criteria of Lesion Activity in Neovascular Age-Related Macular Degeneration: A Consensus Article.
    J Ocul Pharmacol Ther. 2017 Nov 17. doi: 10.1089/jop.2017.0022.
    PubMed     Text format     Abstract available


  41. SUWANNOI P, Chomnawang M, Sarisuta N, Reichl S, et al
    Development of Acyclovir-Loaded Albumin Nanoparticles and Improvement of Acyclovir Permeation Across Human Corneal Epithelial T Cells.
    J Ocul Pharmacol Ther. 2017 Nov 7. doi: 10.1089/jop.2017.0057.
    PubMed     Text format     Abstract available


  42. EATON JS, Miller PE, Bentley E, Thomasy SM, et al
    Slit Lamp-Based Ocular Scoring Systems in Toxicology and Drug Development: A Literature Survey.
    J Ocul Pharmacol Ther. 2017 Nov 7. doi: 10.1089/jop.2017.0021.
    PubMed     Text format     Abstract available


  43. DI ZAZZO A, Roberti G, Mashaghi A, Abud TB, et al
    Use of Topical Cannabinomimetic Palmitoylethanolamide in Ocular Surface Disease Associated with Antiglaucoma Medications.
    J Ocul Pharmacol Ther. 2017;33:670-677.
    PubMed     Text format     Abstract available


    October 2017
  44. PAPANGKORN K, Prendergast E, Higuchi JW, Brar B, et al
    Noninvasive Ocular Drug Delivery System of Dexamethasone Sodium Phosphate in the Treatment of Experimental Uveitis Rabbit.
    J Ocul Pharmacol Ther. 2017 Oct 12. doi: 10.1089/jop.2017.0053.
    PubMed     Text format     Abstract available


  45. MOUSTAFA MT, Ramirez C, Schneider K, Atilano SR, et al
    Protective Effects of Memantine on Hydroquinone-Treated Human Retinal Pigment Epithelium Cells and Human Retinal Muller Cells.
    J Ocul Pharmacol Ther. 2017;33:610-619.
    PubMed     Text format     Abstract available


    September 2017
  46. GARWEG JG, Niderprim SA, Russ HM, Pfister IB, et al
    Comparison of Strategies of Treatment with Ranibizumab in Newly-Diagnosed Cases of Neovascular Age-Related Macular Degeneration.
    J Ocul Pharmacol Ther. 2017 Sep 27. doi: 10.1089/jop.2017.0006.
    PubMed     Text format     Abstract available


  47. LIN CJ, Chen HS, Su CW, Tien PT, et al
    The Effect of Age and Initial Central Retinal Thickness on Earlier Need of Repeat Ozurdex Treatment for Macular Edema Due to Retinal Vein Occlusion: A Retrospective Case Series.
    J Ocul Pharmacol Ther. 2017 Sep 26. doi: 10.1089/jop.2017.0070.
    PubMed     Text format     Abstract available


  48. CORCORAN P, Hollander DA, Ousler GW 3rd, Angjeli E, et al
    Dynamic Sensitivity of Corneal TRPM8 Receptors to Menthol Instillation in Dry Eye Versus Normal Subjects.
    J Ocul Pharmacol Ther. 2017.
    PubMed     Text format     Abstract available


  49. GUERRA M, Marques S, Quadrado Gil J, Campos J, et al
    Neurotrophic Keratopathy: Therapeutic Approach Using a Novel Matrix Regenerating Agent.
    J Ocul Pharmacol Ther. 2017.
    PubMed     Text format     Abstract available


    August 2017
  50. TRESE MGJ, Lewis AW, Blachley TS, Stein JD, et al
    Changing Initial Glaucoma Medical Therapy Increases Healthcare Resource Utilization.
    J Ocul Pharmacol Ther. 2017 Aug 30. doi: 10.1089/jop.2017.0051.
    PubMed     Text format     Abstract available


  51. ZANDI S, Lereuil T, Freiberg F, Pfau M, et al
    Long-Term Intravitreal Dexamethasone Treatment in Eyes with Pretreated Chronic Diabetic Macular Edema.
    J Ocul Pharmacol Ther. 2017 Aug 24. doi: 10.1089/jop.2017.0020.
    PubMed     Text format     Abstract available


  52. FLINEY GD, Zukin LM, Hagedorn C
    Neovascular Age-Related Macular Degeneration Disease Quiescence with Visual Acuity Stability in a Subgroup of Patients Following PRN Treatment.
    J Ocul Pharmacol Ther. 2017 Aug 22. doi: 10.1089/jop.2017.0013.
    PubMed     Text format     Abstract available


  53. HE S, Stankowska DL, Ellis DZ, Krishnamoorthy RR, et al
    Targets of Neuroprotection in Glaucoma.
    J Ocul Pharmacol Ther. 2017 Aug 18. doi: 10.1089/jop.2017.0041.
    PubMed     Text format     Abstract available


  54. HAYS CL, Okafor KC, Fan S, High R, et al
    Consequences of Puberty on Efficacy of Intraocular Pressure-Lowering Drugs in Male Dutch-Belted Rabbits.
    J Ocul Pharmacol Ther. 2017 Aug 18. doi: 10.1089/jop.2016.0168.
    PubMed     Text format     Abstract available


  55. KATSANOS A, Dastiridou AI, Quaranta L, Rulli E, et al
    The Effect of Posture on Intraocular Pressure and Systemic Hemodynamic Parameters in Treated and Untreated Patients with Primary Open-Angle Glaucoma.
    J Ocul Pharmacol Ther. 2017 Aug 16. doi: 10.1089/jop.2017.0030.
    PubMed     Text format     Abstract available


  56. CAVET ME, DeCory HH
    The Role of Nitric Oxide in the Intraocular Pressure Lowering Efficacy of Latanoprostene Bunod: Review of Nonclinical Studies.
    J Ocul Pharmacol Ther. 2017 Aug 7. doi: 10.1089/jop.2016.0188.
    PubMed     Text format     Abstract available


  57. TORIS CB, Gelfman C, Whitlock A, Sponsel WE, et al
    Making Basic Science Studies in Glaucoma More Clinically Relevant: The Need for a Consensus.
    J Ocul Pharmacol Ther. 2017 Aug 4. doi: 10.1089/jop.2017.0001.
    PubMed     Text format     Abstract available


    July 2017
  58. KIM HS, Kim TI, Kim JH, Yoon KC, et al
    Evaluation of Clinical Efficacy and Safety of a Novel Cyclosporin A Nanoemulsion in the Treatment of Dry Eye Syndrome.
    J Ocul Pharmacol Ther. 2017 Jul 31. doi: 10.1089/jop.2016.0164.
    PubMed     Text format     Abstract available


  59. CAIRNS EA, Szczesniak AM, Straiker AJ, Kulkarni PM, et al
    The In Vivo Effects of the CB1-Positive Allosteric Modulator GAT229 on Intraocular Pressure in Ocular Normotensive and Hypertensive Mice.
    J Ocul Pharmacol Ther. 2017 Jul 18. doi: 10.1089/jop.2017.0037.
    PubMed     Text format     Abstract available


  60. GANDHI JK, Roy Chowdhury U, Manzar Z, Buck J, et al
    Differential Intraocular Pressure Measurements by Tonometry and Direct Cannulation After Treatment with Soluble Adenylyl Cyclase Inhibitors.
    J Ocul Pharmacol Ther. 2017 Jul 7. doi: 10.1089/jop.2017.0027.
    PubMed     Text format     Abstract available


  61. PENG SY, Lai CC, Wang NK, Wu WC, et al
    Real-World Experience with Half-Time Versus Half-Dose Photodynamic Therapy in Chronic Central Serous Chorioretinopathy.
    J Ocul Pharmacol Ther. 2017;33:466-472.
    PubMed     Text format     Abstract available


    June 2017
  62. VERHOEVEN RS, Garcia A, Robeson R, Gilger BC, et al
    Nonclinical Development of ENV905 (Difluprednate) Ophthalmic Implant for the Treatment of Inflammation and Pain Associated with Ocular Surgery.
    J Ocul Pharmacol Ther. 2017 Jun 26. doi: 10.1089/jop.2016.0195.
    PubMed     Text format     Abstract available


  63. PATIL R, Wang H, Sharif NA, Mitra A, et al
    Aquaporins: Novel Targets for Age-Related Ocular Disorders.
    J Ocul Pharmacol Ther. 2017 Jun 20. doi: 10.1089/jop.2017.0024.
    PubMed     Text format     Abstract available


  64. LIN CW, Sherman B, Moore LA, Laethem CL, et al
    Discovery and Preclinical Development of Netarsudil, a Novel Ocular Hypotensive Agent for the Treatment of Glaucoma.
    J Ocul Pharmacol Ther. 2017 Jun 13. doi: 10.1089/jop.2017.0023.
    PubMed     Text format     Abstract available



  65. Retraction of: Azithromycin 1.5% Ophthalmic Solution for Blepharitis Treatment: Comparison of 14- Versus 30-Day Treatment; DOI: 10.1089/jop.2015.0099.
    J Ocul Pharmacol Ther. 2017 Jun 12. doi: 10.1089/jop.2015.0099.
    PubMed     Text format    


  66. MORI A, Yabuta C, Kishimoto Y, Kozai S, et al
    In Silico Ocular Pharmacokinetic Modeling: Delivery of Topical FK962 to Retina.
    J Ocul Pharmacol Ther. 2017 Jun 9. doi: 10.1089/jop.2016.0136.
    PubMed     Text format     Abstract available


  67. KOC M, Bostanci B, Demirel OO, Genc F, et al
    The Effect of Ascorbic Acid (Vitamin C) on Transepithelial Corneal Cross-Linking in Rabbits.
    J Ocul Pharmacol Ther. 2017 Jun 7. doi: 10.1089/jop.2017.0025.
    PubMed     Text format     Abstract available


  68. BARANOV P, Lin H, McCabe K, Gale D, et al
    A Novel Neuroprotective Small Molecule for Glial Cell Derived Neurotrophic Factor Induction and Photoreceptor Rescue.
    J Ocul Pharmacol Ther. 2017;33:412-422.
    PubMed     Text format     Abstract available


  69. ROLANDO M, Vagge A
    Safety and Efficacy of Cortisol Phosphate in Hyaluronic Acid Vehicle in the Treatment of Dry Eye in Sjogren Syndrome.
    J Ocul Pharmacol Ther. 2017;33:383-390.
    PubMed     Text format     Abstract available


  70. SANCHEZ-AVILA RM, Merayo-Lloves J, Riestra AC, Anitua E, et al
    The Effect of Immunologically Safe Plasma Rich in Growth Factor Eye Drops in Patients with Sjogren Syndrome.
    J Ocul Pharmacol Ther. 2017;33:391-399.
    PubMed     Text format     Abstract available


    May 2017
  71. GARWEG JG, Gerhardt C, Kodjikian L, Pfister IB, et al
    Real-Life Experience with Aflibercept and Ranibizumab in the Treatment of Newly Diagnosed Neovascular Age-Related Macular Degeneration over 24 Months.
    J Ocul Pharmacol Ther. 2017 May 30. doi: 10.1089/jop.2017.0031.
    PubMed     Text format     Abstract available


  72. FABIANI C, Vitale A, Emmi G, Lopalco G, et al
    Systemic Steroid Sparing Effect of Intravitreal Dexamethasone Implant in Chronic Noninfectious Uveitic Macular Edema.
    J Ocul Pharmacol Ther. 2017 May 30. doi: 10.1089/jop.2017.0034.
    PubMed     Text format     Abstract available


  73. WU YH, Wang LC, Yen SH, Yu WK, et al
    Change of Serum IgG4 in Patients with Ocular Adnexal Marginal Zone B Cell Lymphoma Associated with IgG4-Related Ophthalmic Disease After Treatment.
    J Ocul Pharmacol Ther. 2017 May 17. doi: 10.1089/jop.2016.0175.
    PubMed     Text format     Abstract available


  74. FRERE A, Caspers L, Makhoul D, Judice L, et al
    Single Dexamethasone Intravitreal Implant in the Treatment of Noninfectious Uveitis.
    J Ocul Pharmacol Ther. 2017;33:290-297.
    PubMed     Text format     Abstract available


  75. FOUSSAT A, Gregoire S, Clerget-Chossat N, Terrada C, et al
    Regulatory T Cell Therapy for Uveitis: A New Promising Challenge.
    J Ocul Pharmacol Ther. 2017;33:278-284.
    PubMed     Text format     Abstract available


  76. TERADA Y, Kamoi K, Komizo T, Miyata K, et al
    Human T Cell Leukemia Virus Type 1 and Eye Diseases.
    J Ocul Pharmacol Ther. 2017;33:216-223.
    PubMed     Text format     Abstract available


  77. WEI JR, Wen X, Bible PW, Li Z, et al
    Panax Notoginseng Saponin Controls IL-17 Expression in Helper T Cells.
    J Ocul Pharmacol Ther. 2017;33:285-289.
    PubMed     Text format     Abstract available


    April 2017
  78. CHO HJ, Kim JM, Kim HS, Lee DW, et al
    Effect of Epiretinal Membranes on Antivascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration.
    J Ocul Pharmacol Ther. 2017 Apr 26. doi: 10.1089/jop.2016.0178.
    PubMed     Text format     Abstract available


  79. SCHMIDL D, Werkmeister R, Kaya S, Unterhuber A, et al
    A Controlled, Randomized Double-Blind Study to Evaluate the Safety and Efficacy of Chitosan-N-Acetylcysteine for the Treatment of Dry Eye Syndrome.
    J Ocul Pharmacol Ther. 2017 Apr 25. doi: 10.1089/jop.2016.0123.
    PubMed     Text format     Abstract available


  80. ANTOUN J, Willermain F, Makhoul D, Motulsky E, et al
    Topical Ganciclovir in Cytomegalovirus Anterior Uveitis.
    J Ocul Pharmacol Ther. 2017 Apr 20. doi: 10.1089/jop.2016.0138.
    PubMed     Text format     Abstract available


  81. MOOSAJEE M, Ferguson V
    Response to Aslankurt et al. re: "Safety Profile of Stromal Hydration of Clear Corneal Incisions with Cefuroxime in the Mouse Model".
    J Ocul Pharmacol Ther. 2017 Apr 19. doi: 10.1089/jop.2017.29030.
    PubMed     Text format    


  82. ORAY M, Onal S, Uludag G, Koc Akbay A, et al
    Interferon Alpha for the Treatment of Cystoid Macular Edema Associated with Presumed Ocular Tuberculosis.
    J Ocul Pharmacol Ther. 2017 Apr 17. doi: 10.1089/jop.2016.0097.
    PubMed     Text format     Abstract available


  83. ZHANG P, Wang H, Cao H, Xu X, et al
    Insulin-Like Growth Factor Binding Protein-Related Protein 1 Inhibit Retinal Neovascularization in the Mouse Model of Oxygen-Induced Retinopathy.
    J Ocul Pharmacol Ther. 2017 Apr 12. doi: 10.1089/jop.2016.0171.
    PubMed     Text format     Abstract available


  84. GONZALES JA, Haemel A, Gross AJ, Acharya NR, et al
    Management of Uveitis and Scleritis in Necrobiotic Xanthogranuloma.
    J Ocul Pharmacol Ther. 2017 Apr 10. doi: 10.1089/jop.2016.0135.
    PubMed     Text format     Abstract available


  85. KIM JH, Chang YS, Lee DW, Kim CG, et al
    Incidence and Timing of the First Recurrence in Neovascular Age-Related Macular Degeneration: Comparison Between Ranibizumab and Aflibercept.
    J Ocul Pharmacol Ther. 2017 Apr 6. doi: 10.1089/jop.2016.0098.
    PubMed     Text format     Abstract available


  86. ELBAY A, Ozdemir H, Koytak A, Melikov A, et al
    Intravitreal Dexamethasone Implant for Treatment of Serous Macular Detachment in Central Retinal Vein Occlusion.
    J Ocul Pharmacol Ther. 2017 Apr 4. doi: 10.1089/jop.2016.0187.
    PubMed     Text format     Abstract available


  87. PERENYI K, Dienes L, Kornafeld A, Kovacs B, et al
    The Effect of Tear Supplementation with 0.15% Preservative-Free Zinc-Hyaluronate on Ocular Surface Sensations in Patients with Dry Eye.
    J Ocul Pharmacol Ther. 2017 Apr 4. doi: 10.1089/jop.2016.0194.
    PubMed     Text format     Abstract available


  88. FERNANDEZ-FERREIRO A, Santiago-Varela M, Gil-Martinez M, Gonzalez-Barcia M, et al
    In Vitro Evaluation of the Ophthalmic Toxicity Profile of Chlorhexidine and Propamidine Isethionate Eye Drops.
    J Ocul Pharmacol Ther. 2017;33:202-209.
    PubMed     Text format     Abstract available


  89. GREENE WA, Burke TA, Kaini RR, Por ED, et al
    Polarized Secretion of Matrix Metalloproteinases and Their Inhibitors by Retinal Pigment Epithelium Derived from Induced Pluripotent Stem Cells During Wound Healing.
    J Ocul Pharmacol Ther. 2017;33:132-140.
    PubMed     Text format     Abstract available


  90. RUBSAM A, Thieme CE, Schlomberg J, Winterhalter S, et al
    Therapy Rationale for Mineralocorticoid-Receptor Antagonists, Acetazolamide and a Switch of Therapy in Nonresponders in Central Serous Chorioretinopathy.
    J Ocul Pharmacol Ther. 2017;33:141-148.
    PubMed     Text format     Abstract available


  91. SELEN F, Tekeli O, Yanik O
    Assessment of the Anterior Chamber Flare and Macular Thickness in Patients Treated with Topical Antiglaucomatous Drugs.
    J Ocul Pharmacol Ther. 2017;33:170-175.
    PubMed     Text format     Abstract available


    March 2017
  92. STEM MS, Todorich B, Faia LJ
    Ocular Pharmacology for Scleritis: Review of Treatment and a Practical Perspective.
    J Ocul Pharmacol Ther. 2017 Mar 29. doi: 10.1089/jop.2016.0127.
    PubMed     Text format     Abstract available


  93. PORT AD, Orlin A, Kiss S, Patel S, et al
    Cytomegalovirus Retinitis: A Review.
    J Ocul Pharmacol Ther. 2017 Mar 29. doi: 10.1089/jop.2016.0140.
    PubMed     Text format     Abstract available


  94. HORI Y, Kageyama T, Sakamoto A, Shiba T, et al
    Comparison of Short-Term Effects of Diquafosol and Rebamipide on Mucin 5AC Level on the Rabbit Ocular Surface.
    J Ocul Pharmacol Ther. 2017 Mar 27. doi: 10.1089/jop.2016.0092.
    PubMed     Text format     Abstract available


  95. SCHAAP-FOGLER M, Bahar I, Rephaeli A, Dahbash M, et al
    Effect of Histone Deacetylase Inhibitor, Butyroyloxymethyl-Diethyl Phosphate (AN-7), on Corneal Neovascularization in a Mouse Model.
    J Ocul Pharmacol Ther. 2017 Mar 24. doi: 10.1089/jop.2016.0017.
    PubMed     Text format     Abstract available


  96. SCHNABOLK G, Beon MK, Tomlinson S, Rohrer B, et al
    New Insights on Complement Inhibitor CD59 in Mouse Laser-Induced Choroidal Neovascularization: Mislocalization After Injury and Targeted Delivery for Protein Replacement.
    J Ocul Pharmacol Ther. 2017 Mar 23. doi: 10.1089/jop.2016.0101.
    PubMed     Text format     Abstract available


  97. SMITH WM
    Cyclosporine: A Historical Perspective on Its Role in the Treatment of Noninfectious Uveitis.
    J Ocul Pharmacol Ther. 2017 Mar 13. doi: 10.1089/jop.2016.0155.
    PubMed     Text format     Abstract available


  98. GERY I
    Robert Burton Nussenblatt, MD, MPH (1948-2016), Physician-Scientist, Leading Ophthalmologist and Exemplary Teacher.
    J Ocul Pharmacol Ther. 2017 Mar 7. doi: 10.1089/jop.2017.29027.
    PubMed     Text format    


  99. ASLANKURT M, Andi I, Cekic O
    Re: "Safety Profile of Stromal Hydration of Clear Corneal Incisions with Cefuroxime in the Mouse Model" by Moosajee et al. (J. Ocul. Pharmacol. Ther. 32:469-475, 2016).
    J Ocul Pharmacol Ther. 2017 Mar 6. doi: 10.1089/jop.2016.0183.
    PubMed     Text format    


  100. GOMES RL, Viana RG, Melo LA Jr, Cruz AC, et al
    Aqueous Humor Penetration and Biological Activity of Moxifloxacin 0.5% Ophthalmic Solution Alone or with Dexamethasone 0.1.
    J Ocul Pharmacol Ther. 2017;33:98-102.
    PubMed     Text format     Abstract available


  101. BAO X, Hou M, Qin Y, Luo F, et al
    Effect of an MG132-Sustained Drug Delivery Capsular Ring on the Inhibition of Posterior Capsule Opacification in a Rabbit Model.
    J Ocul Pharmacol Ther. 2017;33:103-110.
    PubMed     Text format     Abstract available


  102. TORKILDSEN G, Abelson MB, Gomes PJ, McLaurin E, et al
    Vehicle-Controlled, Phase 2 Clinical Trial of a Sustained-Release Dexamethasone Intracanalicular Insert in a Chronic Allergen Challenge Model.
    J Ocul Pharmacol Ther. 2017;33:79-90.
    PubMed     Text format     Abstract available


  103. PARK Y, Song JS, Choi CY, Yoon KC, et al
    A Randomized Multicenter Study Comparing 0.1%, 0.15%, and 0.3% Sodium Hyaluronate with 0.05% Cyclosporine in the Treatment of Dry Eye.
    J Ocul Pharmacol Ther. 2017;33:66-72.
    PubMed     Text format     Abstract available


    February 2017
  104. PATIL A, Majumdar S
    Echinocandins in Ocular Therapeutics.
    J Ocul Pharmacol Ther. 2017 Feb 24. doi: 10.1089/jop.2016.0186.
    PubMed     Text format     Abstract available


  105. STAHL E, Bremond-Gignac D, Landry T, Curtis M, et al
    Pharmacokinetics and Safety of Travoprost 0.004% Ophthalmic Solution Preserved with Polyquad in Pediatric Patients with Glaucoma.
    J Ocul Pharmacol Ther. 2017 Feb 24. doi: 10.1089/jop.2016.0133.
    PubMed     Text format     Abstract available


  106. KOZAK I, Shoughy SS, Stone DU
    Intravitreal Antiangiogenic Therapy of Uveitic Macular Edema: A Review.
    J Ocul Pharmacol Ther. 2017 Feb 6. doi: 10.1089/jop.2016.0118.
    PubMed     Text format     Abstract available


  107. YAMADA H, Yoneda M, Inaguma S, Gosho M, et al
    A Rho-Associated Kinase Inhibitor Protects Permeability in a Cell Culture Model of Ocular Disease, and Reduces Aqueous Flare in Anterior Uveitis.
    J Ocul Pharmacol Ther. 2017 Feb 3. doi: 10.1089/jop.2016.0085.
    PubMed     Text format     Abstract available


  108. KUO DE, Wei MM, Armbrust KR, Knickelbein JE, et al
    Gradient Boosted Decision Tree Classification of Endophthalmitis Versus Uveitis and Lymphoma from Aqueous and Vitreous IL-6 and IL-10 Levels.
    J Ocul Pharmacol Ther. 2017 Feb 3. doi: 10.1089/jop.2016.0132.
    PubMed     Text format     Abstract available


    January 2017
  109. SEIBOLD LK, DeWitt PE, Kroehl ME, Kahook MY, et al
    The 24-Hour Effects of Brinzolamide/Brimonidine Fixed Combination and Timolol on Intraocular Pressure and Ocular Perfusion Pressure.
    J Ocul Pharmacol Ther. 2017 Jan 27. doi: 10.1089/jop.2016.0141.
    PubMed     Text format     Abstract available


  110. BRANSON SV, McClafferty BR, Kurup SK
    Vitrectomy for Epiretinal Membranes and Macular Holes in Uveitis Patients.
    J Ocul Pharmacol Ther. 2017 Jan 23. doi: 10.1089/jop.2016.0142.
    PubMed     Text format     Abstract available


  111. CHEN H, Lin H, Chen W, Zhang B, et al
    Topical 0.1% Bromfenac Sodium for Intraoperative Miosis Prevention and Prostaglandin E2 Inhibition in Femtosecond Laser-Assisted Cataract Surgery.
    J Ocul Pharmacol Ther. 2017 Jan 20. doi: 10.1089/jop.2016.0114.
    PubMed     Text format     Abstract available


  112. REVIGLIO VE, Osaba M, Sambuelli G, Kuo IC, et al
    Phototoxic Effect of Topical Fluoroquinolones Administered Before Corneal Crosslinking in a Murine Model.
    J Ocul Pharmacol Ther. 2017 Jan 20. doi: 10.1089/jop.2016.0060.
    PubMed     Text format     Abstract available


  113. ROBINSON J, Okoro E, Ezuedu C, Bush L, et al
    Effects of Hydrogen Sulfide-Releasing Compounds on Aqueous Humor Outflow Facility in Porcine Ocular Anterior Segments, Ex Vivo.
    J Ocul Pharmacol Ther. 2017 Jan 18. doi: 10.1089/jop.2016.0037.
    PubMed     Text format     Abstract available


  114. LIU S, Matsuo T, Hosoya O, Uchida T, et al
    Photoelectric Dye Used for Okayama University-Type Retinal Prosthesis Reduces the Apoptosis of Photoreceptor Cells.
    J Ocul Pharmacol Ther. 2017 Jan 13. doi: 10.1089/jop.2016.0093.
    PubMed     Text format     Abstract available


  115. WANG JW, Vu C, Poloso NJ
    A Prostacyclin Analog, Cicaprost, Exhibits Potent Anti-Inflammatory Activity in Human Primary Immune Cells and a Uveitis Model.
    J Ocul Pharmacol Ther. 2017 Jan 10. doi: 10.1089/jop.2016.0167.
    PubMed     Text format     Abstract available


  116. FUCHS H, Igney F
    Binding to Ocular Albumin as a Half-Life Extension Principle for Intravitreally Injected Drugs: Evidence from Mechanistic Rat and Rabbit Studies.
    J Ocul Pharmacol Ther. 2017 Jan 5. doi: 10.1089/jop.2016.0083.
    PubMed     Text format     Abstract available


  117. BATTAGLIA PARODI M, Donati S, Semeraro F, Danzi P, et al
    Intravitreal Anti-Vascular Endothelial Growth Factor Drugs for Retinal Angiomatous Proliferation in Real-Life Practice.
    J Ocul Pharmacol Ther. 2017 Jan 3. doi: 10.1089/jop.2016.0091.
    PubMed     Text format     Abstract available


  118. PFLUGFELDER SC, Stern M, Zhang S, Shojaei A, et al
    LFA-1/ICAM-1 Interaction as a Therapeutic Target in Dry Eye Disease.
    J Ocul Pharmacol Ther. 2017;33:5-12.
    PubMed     Text format     Abstract available


    December 2016
  119. TABUCHI N, Toshida H, Koike D, Odaka A, et al
    Effect of Retinol Palmitate on Corneal and Conjunctival Mucin Gene Expression in a Rat Dry Eye Model After Injury.
    J Ocul Pharmacol Ther. 2016 Dec 23. doi: 10.1089/jop.2015.0161.
    PubMed     Text format     Abstract available


  120. GUO J, Luo X, Liang J, Xiao M, et al
    Antiangiogenic Effects of Doxazosin on Experimental Choroidal Neovascularization in Mice.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


  121. LIANG IC, Lin YR, Chien HW, Liu KR, et al
    Vision Preservation in Eyes of Polypoidal Choroidal Vasculopathy with Low-Dose Intravitreal Triamcinolone Acetonide.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


  122. HERBORT CP JR, Tugal-Tutkun I, Neri P, Pavesio C, et al
    Failure to Integrate Quantitative Measurement Methods of Ocular Inflammation Hampers Clinical Practice and Trials on New Therapies for Posterior Uveitis.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


  123. KOBASHI H, Kamiya K, Shimizu K
    Randomized Comparison Between Rebamipide Ophthalmic Suspension and Diquafosol Ophthalmic Solution for Dry Eye After Penetrating Keratoplasty.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


  124. SUZUKI T, Yamamoto T, Torikai T, Ohashi Y, et al
    Combination Effect of Cefuroxime and Levofloxacin Against Bacteria Isolated from the Healthy Conjunctival Sac and Endophthalmitis Cases Using a Fractional Inhibitory Concentration Index.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available



  125. Correction to: Journal of Ocular Pharmacology and Therapeutics 2016;32:355-364.
    J Ocul Pharmacol Ther. 2016;32:695.
    PubMed     Text format    



  126. Correction to: Journal of Ocular Pharmacology and Therapeutics 2016;32:606-622.
    J Ocul Pharmacol Ther. 2016;32:695.
    PubMed     Text format    


    November 2016
  127. SENGUL EA, Artunay O, Turkseven Kumral E, Yenerel M, et al
    Retinal Nerve Fiber Layer Thickness Changes in Age-Related Macular Degeneration Treated with Multiple Intravitreal Ranibizumab.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


  128. SENTHILKUMARI S, Sharmila R, Chidambaranathan G, Vanniarajan A, et al
    Epalrestat, an Aldose Reductase Inhibitor Prevents Glucose-Induced Toxicity in Human Retinal Pigment Epithelial Cells In Vitro.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


  129. YOO R, Choi YA, Cho BJ
    Change in Central Corneal Thickness After the Discontinuation of Latanoprost in Normal Tension Glaucoma-Change in Central Corneal Thickness After Stop of Latanoprost.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


  130. KANG S, Choi H, Rho CR
    Differential Effects of Bevacizumab, Ranibizumab, and Aflibercept on the Viability and Wound Healing of Corneal Epithelial Cells.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


    October 2016
  131. JENSEN RJ
    Effects of Antipsychotic Drugs Haloperidol and Clozapine on Visual Responses of Retinal Ganglion Cells in a Rat Model of Retinitis Pigmentosa.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


  132. WOODWARD DF, Wenthur SL, Rudebush TL, Fan S, et al
    Prostanoid Receptor Antagonist Effects on Intraocular Pressure, Supported by Ocular Biodisposition Experiments.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


  133. MANNA S, Augsburger JJ, Correa ZM, Al-Rjoub MF, et al
    Noninvasive Electroretinography Assessment of Intravitreal Sustained-Release Methotrexate Microimplants in Rabbit Eyes.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


  134. YASUDA K, Motohashi R, Kotake O, Nakagawa H, et al
    Comparative Effects of Topical Diclofenac and Betamethasone on Inflammation After Vitrectomy and Cataract Surgery in Various Vitreoretinal Diseases.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


  135. BECKEL JM, Lu W, Civan MM, Mitchell CH, et al
    Treatment of Retinal Disorders with Purinergic Drugs: Beyond Receptors.
    J Ocul Pharmacol Ther. 2016;32:488-489.
    PubMed     Text format    


    September 2016
  136. MINNS MS, Trinkaus-Randall V
    Purinergic Signaling in Corneal Wound Healing: A Tale of 2 Receptors.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


  137. REED K, Li A, Wilson B, Assamoi T, et al
    Enhancement of Ocular In Situ Gelling Properties of Low Acyl Gellan Gum by Use of Ion Exchange.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


    August 2016
  138. JACOBSON KA, Civan MM
    Ocular Purine Receptors as Drug Targets in the Eye.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


  139. POR ED, Greene WA, Burke TA, Wang HC, et al
    Trichostatin A Inhibits Retinal Pigmented Epithelium Activation in an In Vitro Model of Proliferative Vitreoretinopathy.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


  140. GARWEG JG, Baglivo E, Freiberg FJ, Pfau M, et al
    Response of Postoperative and Chronic Uveitic Cystoid Macular Edema to a Dexamethasone-Based Intravitreal Implant (Ozurdex).
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


  141. KIM JH, Chang YS, Kim JW, Kim CG, et al
    Long-Term Outcome and Recurrence of Idiopathic Choroidal Neovascularization Treated with Intravitreal Bevacizumab.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


    July 2016
  142. ISOBE T, Kasai T, Kawai H
    Ocular Penetration and Pharmacokinetics of Ripasudil Following Topical Administration to Rabbits.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


  143. BUI DK, Carvounis PE
    Favorable Outcomes of Filamentous Fungal Endophthalmitis Following Aggressive Management.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


  144. HUANG JM, Pansick AD, Blomquist PH
    Use of Intravenous Vancomycin and Cefepime in Preventing Endophthalmitis After Open Globe Injury.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


  145. SHIN KH, Kim JH, Cho SW, Lee TG, et al
    Efficacy of Intravitreal Bevacizumab for Recurrent Central Serous Chorioretinopathy in Patients Who Had Previously Responded Well to the Same Therapy.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


  146. GARAY-ARAMBURU G, Gomez-Moreno A
    Response #2 to Immediate Intraocular Pressure Tendency Following Intravitreal Delivery of Dexamethasone Implant; Alagoz et al. J. Ocul. Pharmacol. Ther. 32:44-49, 2016.
    J Ocul Pharmacol Ther. 2016;32:344-5.
    PubMed     Text format    


    June 2016
  147. GERBER WM, Meyer D, Smit DP
    Ocular and Cerebrospinal Fluid Penetration of Antiretroviral Agents.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


  148. MOOSAJEE M, Tracey-White D, Harbottle RP, Ferguson V, et al
    Safety Profile of Stromal Hydration of Clear Corneal Incisions with Cefuroxime in the Mouse Model.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


  149. JEON HS, Hyon JY
    The Efficacy of Diquafosol Ophthalmic Solution in Non-Sjogren and Sjogren Syndrome Dry Eye Patients Unresponsive to Artificial Tear.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


  150. SAKATA R, Sakisaka T, Matsuo H, Miyata K, et al
    Effect of Travoprost and Nonsteroidal Anti-Inflammatory Drug on Diurnal Intraocular Pressure in Normal Subjects with Low-Teen Baseline Intraocular Pressure.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


  151. QUERQUES G, Darvizeh F, Querques L, Capuano V, et al
    Assessment of the Real-Life Usage of Intravitreal Dexamethasone Implant in the Treatment of Chronic Diabetic Macular Edema in France.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


  152. TORIS CB, McLaughlin MA, Dworak DP, Fan S, et al
    Effects of Rho Kinase Inhibitors on Intraocular Pressure and Aqueous Humor Dynamics in Nonhuman Primates and Rabbits.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


  153. MAH FS
    Effect on Gel Formation Time of Adding Topical Ophthalmic Medications to ReSure Sealant, an In Situ Hydrogel.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


    May 2016
  154. KIKUSHIMA W, Sakurada Y, Sugiyama A, Tanabe N, et al
    Factors Predictive of Visual Outcome 1 Year After Intravitreal Aflibercept Injection for Typical Neovascular Age-Related Macular Degeneration.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


  155. JOSHI R, Mankowski W, Winter M, Saini JS, et al
    Automated Measurement of Cobblestone Morphology for Characterizing Stem Cell Derived Retinal Pigment Epithelial Cell Cultures.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


  156. YUN H, Zhou Y, Wills A, Du Y, et al
    Stem Cells in the Trabecular Meshwork for Regulating Intraocular Pressure.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


  157. LEACH LL, Croze RH, Hu Q, Nadar VP, et al
    Induced Pluripotent Stem Cell-Derived Retinal Pigmented Epithelium: A Comparative Study Between Cell Lines and Differentiation Methods.
    J Ocul Pharmacol Ther. 2016.
    PubMed     Text format     Abstract available


    April 2016
  158. NOVACK GD
    Eyes on New Product Development.
    J Ocul Pharmacol Ther. 2016;32:133-4.
    PubMed     Text format    


  159. BANSAL P, Garg S, Sharma Y, Venkatesh P, et al
    Posterior Segment Drug Delivery Devices: Current and Novel Therapies in Development.
    J Ocul Pharmacol Ther. 2016;32:135-44.
    PubMed     Text format     Abstract available


    March 2016
  160. NOVACK GD
    Eyes on New Product Development.
    J Ocul Pharmacol Ther. 2016;32:65-6.
    PubMed     Text format    


    January 2016
  161. NOVACK GD
    Eyes on New Product Development.
    J Ocul Pharmacol Ther. 2016;32:1-2.
    PubMed     Text format    


  162. MCKAY BS, Schwartz SG
    Pigmentation and Macular Degeneration: Is There a Role for GPR143?
    J Ocul Pharmacol Ther. 2016;32:3-4.
    PubMed     Text format    


  163. CUCHACOVICH M, Solanes F, Perez C, Verdaguer JI, et al
    Mycophenolate Mofetil Therapy in Refractory Inflammatory Eye Disease.
    J Ocul Pharmacol Ther. 2016;32:55-61.
    PubMed     Text format     Abstract available


  164. LINARES-ALBA MA, Gomez-Guajardo MB, Fonzar JF, Brooks DE, et al
    Preformulation Studies of a Liposomal Formulation Containing Sirolimus for the Treatment of Dry Eye Disease.
    J Ocul Pharmacol Ther. 2016;32:11-22.
    PubMed     Text format     Abstract available


  165. KOWALSKI RP, Romanowski EG, Yates KA, Mah FS, et al
    An Independent Evaluation of a Novel Peptide Mimetic, Brilacidin (PMX30063), for Ocular Anti-infective.
    J Ocul Pharmacol Ther. 2016;32:23-7.
    PubMed     Text format     Abstract available


  166. WATANABE A, Tsuzuki A, Arai K, Gekka T, et al
    Efficacy of Intravitreal Triamcinolone Acetonide for Diabetic Macular Edema After Vitrectomy.
    J Ocul Pharmacol Ther. 2016;32:38-43.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ophthalmology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: